THERAPEUTICSMD INC (TXMD) Stock Income Statement
NASDAQ:TXMD - Nasdaq - US88338N2062 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.76M | 1.30M | 69.96M | 2.57M | 64.87M | |||
| Cost Of Goods | N/A | 0.00 | 1.40M | 1.40M | 15.97M | |||
| Gross Profit | N/A | 1.30M | 68.57M | 1.17M | 48.90M | |||
| Operating Expenses | 5.25M | 9.82M | 57.90M | 80.75M | 204.44M | |||
| Research and Development | N/A | N/A | 0.00 | 0.00 | 10.43M | |||
| Selling, General, and Administrative Expenses | 4.74M | 8.90M | 57.90M | 80.75M | 192.96M | |||
| Operating Income | -3.49M | -8.52M | 10.66M | -79.58M | -155.54M | |||
| Interest Income/Expense | 135.40K | 100.00K | N/A | -32.92M | -28.58M | |||
| Other Income/Expense | 2.28M | 681.00K | -120.00K | 270.00K | 600.00K | |||
| Non Recurring Items | -1.27M | 0.00 | -9.47M | 0.00 | 0.00 | |||
| Income Before Taxes | -2.34M | -7.74M | 1.07M | -79.31M | -183.52M | |||
| Income Tax | -31.00K | -43.00K | 0.00 | 0.00 | 0.00 | |||
| Net Income | -2.18M | -10.28M | 112.00M | -172.42M | -183.52M | |||
| EBITDA | -2.98M | -7.60M | 11.85M | -78.84M | -154.50M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.20 | -0.98 | 11.95 | -21.66 | -33.29 | |||
| Non GAAP EPS | N/A | N/A | 11.80 | -21.50 | -33.50 | |||
| Statistics | ||||||||
| Gross Profit Margin | N/A | 100.00% | 98.01% | 45.53% | 75.38% | |||
| Profit Margin | -123.85% | -789.40% | 160.09% | -6708.95% | -282.90% | |||
| Operating Profit Margin | -198.30% | -654.61% | 15.24% | -3096.50% | -239.77% | |||
All data in USD